
Expert Insights: From animal to iPSC-derived models, a new era in preclinical evaluation

Adoption of complex disease modeling brings new optimism and hope to drug discovery

Expert Insights: Large-scale manufacture of iPSC models

Interview: Leveraging iPSCs to accelerate drug discovery

Expert Insights: 3D human iPSC-based cardiac models

Expert Insights: iPSC-derived cardiomyocytes for cardiac drug discovery